Akebia Therapeutics reported $19.71M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
Akebia Therapeutics AKBA:US USD 19.71M 5.24M
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Amgen AMGN:US USD 1.2B 52M
Ardelyx ARDX:US USD 3.11M 1.18M
Astellas Pharma 4503:JP JPY 146.53B 5.69B
Avrobio Inc AVRO:US USD 1.81M 1.79M
Bayer BAYN:GR EUR 6.55B 452M
Exelixis EXEL:US USD 30.57M 10.59M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Ironwood Pharmaceuticals IRWD:US USD 795K 478K
Karyopharm Therapeutics KPTI:US USD 813K 881K
Lexicon Pharmaceuticals LXRX:US USD 9.43M 2.08M
Moderna Inc MRNA:US USD 330M 149M
Nektar Therapeutics NKTR:US USD 5.33M 7.02M
Opko Health OPK:US USD 49.8M 6.31M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K